11/3/15 ACA and Addiction Treatment and Recovery: What Every Addiction Professional Needs to Know Misti Storie, MS, NCC Director of Training Presented by Eric Goplerud, PhD NAADAC, the Association for Addiction Professionals www.naadac.org [email protected] November 4, 2015 www.naadac.org/webinars Produced By NAADAC, the Association for Addiction Professionals www.naadac.org/webinars CE Certificate www.naadac.org/acaandaddictiontreatment Cost to Watch: Free CE Hours Available: 1 CE CE Certificate for NAADAC Members: Free CE Certificate for Non-members: $15 To obtain a CE Certificate for the time you spent watching this webinar: 1. Watch this entire webinar. 2. Pass the online CE quiz, which is posted at www.naadac.org/acaandaddictiontreatment 3. If applicable, submit payment for CE certificate or join NAADAC. 4. A CE certificate will be emailed to you within 21 days of submitting the quiz. 1 11/3/15 Webinar Learning Objectives Using GoToWebinar – (Live Participants Only) 1 § Control Panel 2 3 § Asking Questions Understand the new health system landscape as a result of the ACA § Audio (phone preferred) Understand how the ACA affects your professional practice Identify how SBIRT can be integrated in order to prepare helping professionals to work in the framework of the ACA and the desired integration of substance abuse services into primary care Definitions Eric Goplerud, PhD • ACA – Affordable Care Act Senior Vice President and Fellow Public Health Department NORC at the University of Chicago [email protected] • MHPAEA - The Mental Health Parity and Addiction Equity Act • SBIRT – Screening, Brief Intervention, and Referral to Treatment 11 Substance use risk did not match health coverage pre-ACA and pre-MHPAEA Percentage 100 Over 90% of use and 90 But likelihood of coverage for substance use increases as prevalence declines problems 80 start 70 between the ages of 60 12-20 People with SUDs die an average of 22.5 years sooner than those without a diagnosis 50 High risk alcohol/drug use in the past year 40 Substance Use Disorder in the past year 30 20 • 21.6 million had SUDs (8.2% US pop 12 y.o. and older) • 47.5 million Americans lacked health insurance – 14.6% uninsured adults have SUDs – Treatment rate uninsured was12.8% • 33% of those covered by individual insurance had no SUD coverage; • 5% in small group insurance no SUD coverage 65+ 50-64 35-49 30-34 21-29 18-20 16-17 14-15 12-13 10 0 Health Insurance Coverage for SUD Pre-MHPAEA and ACA Age Source: 2002 NSDUH and Dennis & Scott, 2007, Neumark et al., 2000 13 2 11/3/15 Pre-ACA and Pre-MHPAEA: SUDs are Common, But Treatment Rates are Low Few Get Treatment: 1 in 20 adolescents, 1 in 18 young adults, 1 in 11 adults 25% MHPAEA and ACA are about... coverage and access 20.1% 20% 15% 10% 7.4% 7.0% 5% 0% 1.1% 0.4% 12 to 17 18 to 25 0.6% Abuse or Dependence in past year Treatment in past year 26 or older Source: SAMHSA 2010. National Survey On Drug Use And Health, 2010 [Computer file] The way that ACA and MHPAEA is supposed to work (and does in Medicaid expansion states) Medicaid Expansion State/Federal Marketplaces Employer Coverage Extent of MHPAEA and ACA Parity Coverage ERISA-governed self-insured plans Yes, cost and size exemptions may apply ERISA-governed fully insured plans Yes, size and cost exemptions apply State-regulated group and individual insurance markets Medicaid fee-for-service Medicaid managed care Yes, applies to issuers who sell coverage to employers with 50+ empl. No, CMS Medicaid standards apply. Yes, CMS Medicaid managed care standards apply. 4/10/15 NPRM Yes No No Yes, Essential Benefit, for small group and individual offerings No, but FEHBP adopted MHPAEA. No, MHPAEA not adopted. No, churches are exempt Yes, but plan sponsors may opt out. Separately administered CHIP plans Medicare fee-for-service market Medicare Advantage Federal and State health insurance exchanges The Federal Employee Health Benefits TriCare Church plans Nonfederal public-employee plans 17 Extension of Parity to Medicaid Managed Care Organizations (~70% of all Medicaid beneficiaries) Parity and ACA extends Coverage of MH/SUD Proposed Rule by CMS 04/10/2015 • if a state uses private health plans or MCOs to provide any of its state plan benefits under an MCO contract, enrollees in those MCOs (whether under a voluntary or mandatory managed care program) must receive the protections of MHPAEA for MH/SUD services. • For beneficiaries who are not enrolled in a MCO (FFS only) proposed rule would not affect coverage • 18 months after the date of the publication of the final rule to comply New coverage for Expanded MH MH and SUD care and SUD care coverage Total Individuals currently 3.9 7.1 11 holding individual Estimates coverage indicate that 2.8 million adults may receive Behavioral Health treatment through Medicaid Individuals currently 1.2 23.2 24.5 expansions, with coverage and 3.1 million through participation in health insurance under small group exchanges. plans Uninsured Total 27 --- 27 32.1 30.4 62.5 Frank, R. G., Beronio, K., & Glied, S. A. (2014). Behavioral health parity and the affordable care act. Journal of social work in disability & rehabilitation, 13(1-2), 31-43. 19 3 11/3/15 Substance Use Prevention and Treatment Mandatory Essential Health Benefits in HIEs Medicaid expansion and non-expansion states 1. Ambulatory services 6. Prescription drugs 2. Emergency services 7. Rehabilitative and habilitative services and devices 3. Hospitalization 8. Laboratory services 4. Maternity and newborn care 9. Preventive and wellness services and chronic disease management 5. Mental health and substance use disorder services, including behavioral health treatment 10. Pediatric services, including oral and vision care American Mental Health Counselors Association. Dashed Hopes; Broken Promises; More Despair: How the Lack of State Participation in the Medicaid Expansion Will Punish Americans with Mental Illness. 20 (2014). http://www.amhca.org/assets/content/AMHCA_DashedHopes_Report_2_21_14_final.pdf ACA requires Private Health Plans to cover Preventive Services • Includes: • Self-‐insured employer plans (ERISA plans) • Individual insurance plans (plans purchased by individuals) • Small and Large group plans (plans employers buy for workers) • Plans that are “grandfathered” are exempt Preven,ve Services Covered w/o Cost Sharing Cancer Chronic Condi,ons Vaccines Healthy Behaviors Pregnancy ü Breast Cancer ü Cardiovascular health ⁻ Hypertension screening ⁻ Lipid disorders screenings ⁻ Aspirin ü Td booster, Tdap ü Alcohol misuse screening and counseling (all adults) ü Type 2 Diabetes ü Hepa,,s A, B – Mammography for women 40+* – GeneHc (BRCA) screening and counseling – PrevenHve medicaHon ü Cervical Cancer ‒ Pap tesHng (women 21+ ) ‒ High-‐risk HPV DNA tes,ng ♀ ü Colorectal Cancer ⁻ • Requirement also applies to plans that are available in the state Marketplaces because prevenHve services are considered an EssenHal Health Benefit screening (adults w/ elevated blood pressure) ü MMR ü Meningococcal ü Pneumococcal ü Zoster ü Influenza, ü Depression screening (adults, when follow up supports available) ü Varicella ü Osteoporosis One of following: screening (all women fecal occult blood 65+, women 60+ at tesHng, colonoscopy, high risk) sigmoidoscopy ü HPV (women and men 19-‐26) ü Depression screening and brief counseling ü Tobacco counseling (all adults) Counseling and behavioral intervenHons (obese adults) intervenHons ü Alcohol misuse screening/counseling ü Rh incompa,bility screening ü Gesta,onal diabetes ⁻ ⁻ and cessa,on interven,ons ü Interpersonal and domes,c violence screening and counseling ♀ ü Diet counseling (adults w/high cholesterol, CVD risk factors, diet-‐related chronic disease) ü Obesity Screening ü Tobacco and cessa,on screenings♀ 24-‐28 weeks gesta,on First prenatal visit (women at high risk for diabetes) ü Screenings ⁻ ⁻ ⁻ ⁻ ⁻ HepaHHs B Chlamydia (<24, hi risk) Gonorrhea Syphilis Bacteriurea ü Folic acid supplements (women w/repro capacity) ü Iron deficiency anemia screening ü Well-‐woman visits ü BreasYeeding supports, ⁻ counseling , consulta,ons and equipment rental♀ Reproduc,ve and Sexual Health ü STI and HIV counseling (adults at high risk; all sexually-‐ ac,ve women♀) ü Screenings: ⁻ Chlamydia (sexually acHve women <24y/o, older women at high risk) ⁻ Gonorrhea (sexually acHve women at high risk) ⁻ Syphilis (adults at high risk) ⁻ HIV (adults at high risk; all sexually ac,ve women♀) ü Contracep,on (women w/repro capacity) ♀ ⁻ All FDA approved methods as prescribed, ⁻ Steriliza,on procedures ⁻ Pa,ent educa,on and counseling SOURCE: U.S. DHHS, “Recommended Preventive Services.” Available at http://www.healthcare.gov/center/ regulations/prevention/recommendations.html. Health Exchanges – Individual & Small Group Markets • Federally Facilitated Exchanges (38 states), and State-Operated Exchanges (12 and DC). • Third enrollment period started November 1, 2015 and runs through January 2016. • Scope is uninsured adults above 133 percent of the Federal poverty level (plus discounted 5 percent of income). • Premium subsidies up to 400% poverty level • From 133% poverty in Medicaid expansion states • From 100% poverty in non-expansion states What Healthcare Plans Are Available? • Platinum: Insurance pays 90 percent of covered medical expenses. • Gold: Insurance pays 80 % of covered medical expenses. • Silver: Insurance pays 70 % of covered medical expenses. • Bronze: Insurance pays 60 percent of covered medical expenses. 4 11/3/15 Coverage in Medicaid Expansion States Individual mandate • Require all citizens and legal residents (there are some exceptions) to have health coverage in 2014. • What happens if someone does not meet this deadline? • Will they go to jail? NO! • Exceptions: Religious objections, Undocumented immigrant, Incarcerated, American Indians and Alaskan Natives, Income below the tax filing threshold, The lowest cost plan option exceeds 9.5 percent of an individual’s income Medicaid Expansion Coverage in non-Medicaid Expansion States So, what is happening and projected to happen? Parity Coverage Location of care Implications of MHPAEA and ACA for SUD Prevention and Treatment Integrating behavioral health and primary care Implications of MHPAEA and ACA for SUD Prevention and Treatment • SUD treatments will be provided within the primary care setting. Increasing eligibility of coverage for children up to age 26 under their parents’ plans • Reimbursement for treatment will be similar to other chronic diseases needing long-term management. Emphasizing prevention of high risk alcohol use Eliminating lifetime caps on SUDs will be treated, managed, and monitored over a essential benefits and lifetime like other chronic illnesses. supporting health care homes • Preventive services for alcohol use risk is covered (e.g., routine screening of substance use and related problems, brief intervention, and referral to treatment). Allowing individuals with a • Previously uninsured individuals (due to a pre-existing pre-existing condition to have condition) will have insurance coverage for SUD treatment. insurance coverage • Individuals who received SUD treatment in the public sector or from other specialty programs will receive SUD care in the mainstream health care system. Expanding Medicaid Young adults – the group with an elevated rate of SUDs – will be covered for prevention services and treatment for SUDs. • It will bring coverage to a large number of new enrollees. • Substance use treatments including medications will be covered. 30 New organizations bearing financial and clinical risk, using integrated EHRs Medicaid health homes/Integrated care entities will require access to SUD information in order to provide patients with improved, coordinated care (2703 of ACA) Substance use disorders and Addiction is viewed as disease of the brain treatment integrated into medical system Increased role of physicians along with clinicians and peer support recovery specialists to treat and sustain long term recovery 31 5 11/3/15 Trends in Insurance Status for SUD Admissions Pre/Post ACA SAMHSA (2014) Projections of National Expenditures for Treatment of Mental and Substance Use Disorders, 2010-2020 32 SAMHSA (2014) Projections of National Expenditures for Treatment of Mental and Substance Use Disorders, 2010-2020 34 . Saloner, B., Antwi, Y. A., Maclean, J. C., & Lê Cook, B. Access to health insurance and utilization of public sector substance use treatment: Evidence from the Affordable Care Act 33 dependent coverage provision. SAMHSA (2014) Projections of National Expenditures for Treatment of Mental and Substance Use Disorders, 2010-2020 Foreshadowing MHPAEA and ACA Impact: SUD Treatment Rate by State Parity Status: Federal Employees Health Benefit Parity Evaluation Foreshadowing MHPEA and ACA Results? 35 • No difference in rates of access to substance use treatment between FEHB and non-FEHB plans. • For patients receiving substance use treatment, out-of-pocket spending declined significantly relative to non-FEHB plans (difference=−$101.09) • Total spending for substance use treatment did not differ • 10% more patients identified with a new SUD • No differences in initiation and engagement in substance use treatment. CONCLUSIONS—”parity improves insurance protection but has little impact on utilization, costs to plans, or quality of care.” Azzone, V., Frank, R. G., Normand, S. L. T., & Burnam, M. A. (2014). Effect of insurance parity on substance abuse treatment. 36 Wen, H., Cummings, J. R., Hockenberry, J. M., Gaydos, L. M., & Druss, B. G. (2013). State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity 37 legislation. JAMA psychiatry, 70(12), 1355-1362. 6 11/3/15 Do Health Insurance Plans in Exchanges Comply with Parity? Maybe, most of the time (2015 study in 2 states) Preparedness of Substance Use Providers for MHPAEA and Parity • 75% had quantitative treatment limits and prior authorization requirements equivalent to medical-surgical benefits • Health Reform Readiness Index (HRRI) for specialty SUD treatment organizations for ACA. • 427 SUD organizations participated -2010-2012 • In smaller exchange, about half plans discrepant – mostly prior authorization • Most in the early stages of preparation • In larger exchange, more likely to encounter inconsistent financial requirements • Organizations with annual budgets < $5 million (n = 295) were less likely to be prepared for ACA than organizations with annual budgets > $5 million • Co-pays, co-insurance and deductibles • Substance use financial requirements greater than MH • Inappropriate matching behavioral health with medical specialists Berry, K. N., Huskamp, H. A., Goldman, H. H., & Barry, C. L. (2015). A Tale of Two States: Do Consumers See Mental Health Insurance Parity When Shopping on State Exchanges?. Psychiatric Services. 38 Molfenter, T. D. (2014). Addiction treatment centers' progress in preparing for health care reform. Journal of substance abuse treatment, 46(2), 158-164. 39 Screening and Brief Interventions in Hospital Emergency Departments Opportunities for SBIRT Cochrane Collaboration review (McQueen et al, 2011) 14 RCTs, adults and adolescents Hotspot 1: Hospitals Outcomes favor BI over non-treatment controls • • • • Systematic review of ED SBI 12 RCTs with pre- and post-BI results 11 or 12 observed significant effects on alcohol intake, risky drinking practices, alcohol related negative consequences, injury frequency Significant drop in 6 month alcohol consumption Significant drop in alcohol consumption at 9 months Self Report at 1 year favor BI Significantly fewer deaths at 6 months and 1 year Nilsen et al, J Sub Ab Treat. 2008 40 Gundersen Lutheran Hospital, La Crosse, WI: Inpatient SBIRT Program Cost Hospital SBIRT for Acutely Medically Ill, Traumatically Injured and ED Patients • Hospital-wide screening for high risk and dependent substance use implemented with no additional FTE – extension from Trauma Center • Falmouth Hospital (MA) • Denver General Hospital (CO) • Gunderson Lutheran Hospital (WI) • Oregon Health Sciences University (OR) • Christiana Hospital (DE) • Salina Regional Hospital (KS) • Boston Medical Center (MA) • Yale-New Haven (CT) • Assessment responsibility of nursing admission Built into Gunderson’s process Electronic Health Record • All hospital inpatients 365 days per year to includes smoking, alcohol, and psychotherapeutic medication misuse and illicit drug use 42 7 11/3/15 Hospital SBIRT Reimbursement Integrating SBI reimbursement into the EHR http://www.sbirtoregon.org/ Payer Code Commercial Insurance, Medicaid Commercial Insurance, Medicaid SBIRT a Profit Center for Health System – Inpatient, Emergency Department, Ambulatory Clinics 99408 99409 Medicare G0396 Medicare G0397 Medicaid H0049 Medicaid H0050 ED Fee Schedule Description Alcohol and/or substance abuse structured screening and brief intervention services; 15 to 30min Alcohol and/or substance abuse structured screening and brief intervention services; greater than 30min Alcohol and/or substance abuse structured screening and brief intervention services; 15 to 30min Alcohol and/or substance abuse structured screening and brief intervention services; greater than 30min Alcohol and/or drug screening (code not widely used) Alcohol and/or drug service, brief intervention, per 15 min (code not widely used) $85 $185 $32 $65 $24 $48 45 Kaiser-Permanente Northern California’s Early Start: A transformational program that is cost beneficial Hotspot 2: Prenatal Screening and Case Management • Universal Screening of ALL pregnant women • Screening questionnaire • Urine toxicology (with consent) • Place a licensed mental health provider in the department of OB/ GYN • Link the Early Start appointments with routine prenatal care appointments • Educate all women and providers 46 RATE OF INTRAUTERINE FETAL DEMISE (stillborn) Maternal and Infant Mean Costs Comparison $30,000 7.1% 7.0% $25,000 6.0% 5.0% $20,000 4.0% $15,000 3.0% 2.0% 0.5% 0.8% 0.6% 1.0% $10,000 $5,000 0.0% Screen +, Followup Screen+, Assess Screen + Controls Stillborns (IUFDs) were 14.2 times more likely in the S group than the SAF or C groups $0 Screen +, Followup Maternal Total Costs Screen +, Assess Infant Total Costs Screen + Controls Maternal and Infant Costs Combined 8 11/3/15 Hotspot 3: Ambulatory Primary Care SBIRT www.sbirteducation.com But most important – it’s about people 50 51 NORC Analysis of Key Elements to Successful Integration of Key Elements to Successful SBIRT Integration in Primary SBIRT into Primary Care Care • Inner setting • • Intervention characteristics Consolidated Framework for Implementation Research • Organizational development consultation • Competency-based training of BH clinicians in SA • SA records integrated as part of EHRs • Support must come from leaders • Standardized, brief BH screener • Adapt substance risk assessment and intervention to setting • Characteristics of Individuals • Outer setting • Continuing SA education for PC and BH personnel • SA training in pre-professional workforce development • Standardize SBI metrics for electronic records • SBI as an essential element of PCMHs • Remove provider communication restrictions – 42 CFR Part 2 • Remove reimbursement barriers • Integrate SA services throughout PC-BH integration efforts • Implementation • Create SUD quality enhancement center for primary care ASPE Briefing: SBIRT in FQHCs 3-25-15 ASPE Briefing: SBIRT in FQHCs 3-25-15, NORC Average Number of Community Health Center Staff, Visits and Patients SBIRT Reimbursement in Primary Care 2009 2010 2011 2012 Total Medical FTEs 38.4 41.4 43.6 44.4 Substance Use FTEs 0.7 0.8 1.1 1.1 Total Medical July 27, 2015 Encounters/Visits 53298 51198 50080 HRSA $100 million in new funding to51401 300 FQHCss to expand SUD Substance Use to 11 states to expand medication assisted treatment SAMHSA $11 million services Encounters/Visits 1003 1005 1336 1278 CMS isMedical releasing guidance to help states implement comprehensive, Total Patients 15232 15939 15385evidence15091 based SUD treatment Substance Use Patients 123 108 137 147 HHS Launches Multi-pronged Effort to Combat Opioid Abuse ASPE Briefing: SBIRT in FQHCs 3-25-15 54 9 11/3/15 Impact of SBI on Utilization in an Employment-Based Health Plan Hotspot 4: Treatment of SUDs with Medications • BH inpatient days decreased 63% • Medical inpatient days decreased 51% • ER visits decreased 20% • Partial Hospital and IOP visits increased 81% • Psychiatrist visits increased 31% • Therapist visits increased 22% • Net total medical cost savings 15% (N = 247, 12 month continuous enrollment prior and post SBI) Total Cost/Opiate Dependent Pa,ent in 6 months post 18000 57 Comparison of Massachusetts Medicaid Treatment Alternatives: 2003-2007 16000 Buprenorphine Methadone Drug Free No Tx 12000 10000 8000 6000 Medicaid expenditures/ person/month in 6 months post-index date (average $1,220/month) $0.00 $28.70 Relapse Odds Ratio in 6 months post-index date 1.0 0.72*** 1.25*** 2.97*** Deaths Odds Ratio in 6 months post-index date 1.0 0.91 1.75*** 2.25*** $50** $148.5*** 4000 2000 0 Depot NTX 8582 Oral NTX 8903 Bupe 10049 Meth 16752 Drug-‐free 14353 Baser O, Chalk M, Fielin DA, Gastfriend DR. Cost and utilization outcomes of opioiddependence treatments. Am J Managed Care, 2011:17(6);S235-248. 6 Months Post-‐index Total Cost/Alcohol Dependent Pa,ent $12,000 $10,000 $8,000 $6,000 $4,000 $2,000 $0 Depot NTX Oral NTX Clark RE, Samnaliev M, Baxter JD, Leung GY. The evidence doesn’t justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine. Health Affairs. 2011:30(8);1425-1433. Associated Challenges under the ACA MH/SUD treatment will need to $14,000 Cost per pa,ent in 6 months Cost per pa,ent $ 14000 $6,757 $6,595 Disulfiram $7,107 Acamprosate $10,345 Drug-‐free $11,677 integrate with physical medicine/ primary health care despite conflicts in the ways that each handles confidential patient information Medicaid health homes/Integrated care entities will require access to SUD information in order to provide patients with improved, coordinated care (2703 of ACA) Addiction is viewed as disease of the brain Increased role of physicians along with clinicians and peer support recovery specialists to treat and sustain long term recovery Baser O, Chalk M, Fiellin DA, Gastfriend DR. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence. Am J Manag Care. 2011:17(8);S222-234. 10 11/3/15 Revising 42 CFR Part 2? • Federal regulations at 42 CFR Part 2 are over 40 years old Integrated Care: How important do you think care integration of substance use is to improved outcomes? 3.70% 1.20% • Is it time for change? Are we ready? What do patients want and need when it comes to privacy? • ACA emphasizes preventive holistic care and wellness, such that individuals are being treated by their primary and specialty care providers in a coordinated way 16.80% Very Important Important • These aims appear to directly conflict with the restrictions of 42 CFR Part 2 78.30% Somewhat Important Unimportant August 13, 2013 Popovits/Vendome Webinar Poll Results Outlook with MHPAEA and ACA: Transforming Substance Use Screening and Treatment Change Happens: • SUD screening and treatment will be widely dispersed • Less prominent federally-assisted, grant-funded, stand alone SUD facilities • More integrated programs/care systems where both general medical and SUD screening & treatment is delivered (ACOs, medical homes, health homes) • Health care industry standard of freely exchanged health information • Hotspots will be early adopters of integrated SU care • Passage of laws does not immediately result in improved access, improved quality or reduced costs – vigilance, advocacy and planning are needed References and a website Smyth, Hoffman, Fan, Hser, Years of potential life lost among heroin addicts 33 years after treatment. Prev. Med, 2007; 44(4) 132-140. Jones, Moore, Sindelar, O’Connor, Schottenfeld, Fiellin. Cost analysis of clinic and office-based treatment of opioid dependence. Drug Alcohol Depend. 2009;99(1-3): 132-140 Knudsen HK, Abraham AJ. Perceptions of state policy environment and adoption of medications in treatment of substance use disorders. Psych Services. 2012:63(1);19-25. Baser O, Chalk M, Fielin DA, Gastfriend DR. Cost and utilization outcomes of opioid-dependence treatments. Am J Managed Care, 2011:17(6);S235-248. Clark RE, Samnaliev M, Baxter JD, Leung GY. The evidence doesn’t justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine. Health Affairs. 2011:30(8);1425-1433. Vital Signs: Overdoses of Prescription Opioid Pain Relievers --- United States, 1999—2008 MMWR, November 4, 2011 / 60(43);1487-1492 Baser O, Chalk M, Fiellin DA, Gastfriend DR. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence. Am J Manag Care. 2011:17(8);S222-234. Bhati et al (2008) To Treat or Not To Treat: Evidence on the Prospects of Expanding Treatment to Drug-Involved Offenders. Washington, DC: Urban Institute. Health Serve Res. 2006 February; 41(1): 192–213. Susan L Ettner, David Huang, Elizabeth Evans, Danielle Rose Ash, Mary Hardy, Mickel Jourabchi, and Yih-Ing Hser The economic costs of substance abuse treatment: Updated estimates and cost bands for program assessment and reimbursement, Journal of Substance Abuse Treatment(2008) Rose G. Sick individuals and sick populations. International Journal of Epidemiology 1985;14:32-38. Goler, N. C., Armstrong, M. A., Osejo, V. M., Hung, Y. Y., Haimowitz, M., & Caughey, A. B. (2012). Early Start: A Cost–Beneficial Perinatal Substance Abuse Program. Obstetrics & Gynecology, 119(1), 102-110. Mauer B. Substance Use Disorders and The Person-Centered Healthcare Home. Washington DC: National Council for Community Behavioral Healthcare; February 12, 2010 2010. Porcerelli JH, Fowler SL, Murdoch W, Markova T, Kimbrough C. TRAINING FAMILY MEDICINE RESIDENTS TO PRACTICE COLLABORATIVELY WITH PSYCHOLOGY TRAINEES. Int J Psychiatry Med. 2013;45(4):357-365. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4(1):50. Johnson RE, Strain EC, Amass L. Buprenorphine: how to use it right. Drug and alcohol dependence. 2003;70(2):S59-S77. Mattick RP, Breen C, Kimber J, Davoli M, Breen R. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2003;2. Kranzler HR, Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta‐analysis. Alcoholism: Clinical and Experimental Research. 2001;25(9):1335-1341. • Information www.sbirteducation.com “Nothing is permanent, but change” Heraclitus 535-475 BCE “It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change” Charles Darwin 1809-1882 References O'Donnell A, Anderson P, Newbury-Birch D, et al. The impact of brief alcohol interventions in primary healthcare: A systematic review of reviews. Alcohol and alcoholism. 2014;49(1):66-78. Moyer A, Finney JW, Swearingen CE, Vergun P. Brief interventions for alcohol problems: a meta‐analytic review of controlled investigations in treatment‐seeking and non‐treatment‐seeking populations. Addiction. 2002;97(3):279-292. Beich A, Thorsen T, Rollnick S. Screening in brief intervention trials targeting excessive drinkers in general practice: systematic review and meta-analysis. Bmj. 2003;327(7414):536-542. Berglund M, Thelander S, Jonsson E. Treating alcohol and drug abuse: an evidence based review. John Wiley & Sons; 2003. Ballesteros J, Duffy JC, Querejeta I, Ariño J, González-Pinto A. Efficacy of Brief Interventions for Hazardous Drinkers in Primary Care: Systematic Review and Meta-Analyses. Alcoholism: Clinical and Experimental Research. 2004b;28(4):608-618. Cuijpers P, Riper H, Lemmers L. The effects on mortality of brief interventions for problem drinking: a meta‐analysis. Addiction. 2004;99(7): 839-845. Jonas DE, Garbutt JC, Brown JM, et al. Screening, Behavioral Counseling, and Referral in Primary Care to Reduce Alcohol Misuse. 2012. Chang G. Brief interventions for problem drinking and women. J Subst Abuse Treat. 2002;23(1):1-7. Kaner E, Beyer F, Dickinson H, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007;2. Jackson R, Johnson M, Campbell F, et al. Screening and brief interventions for prevention and early identification of alcohol use disorders in adults and young people. Sheffield: University of Sheffield, School of Health and Related Research (ScHARR) Public Health Collaborating Centre. 2010. Latimer N, Guillaume L, Goyder E, Chilcott J, Payne N. Prevention and Early Identification of Alcohol Use Disorders in Adults and Young People: Screening and Brief Interventions. Cost Effectiveness Review Sheffield: University of Sheffield, School of Health and Related Research (ScHARR) Public Health Collaborating Centre. 2010. Jenkins RJ, McAlaney J, McCambridge J. Change over time in alcohol consumption in control groups in brief intervention studies: systematic review and meta-regression study. Drug and alcohol dependence. 2009;100(1):107-114. Bernstein JA, Bernstein E, Heeren TC. Mechanisms of change in control group drinking in clinical trials of brief alcohol intervention: implications for bias toward the null. Drug and alcohol review. 2010;29(5):498-507. McCambridge J, Kypri K. Can simply answering research questions change behaviour? Systematic review and meta analyses of brief alcohol intervention trials. PLoS ONE. 2011;6(10):e23748. ASPE Briefing: SBIRT in FQHCs 3-25-15 11 11/3/15 References Eric Goplerud, PhD Huibers MJ, Beurskens AJ, Bleijenberg G, van Schayck CP. The effectiveness of psychosocial interventions delivered by general practitioners. Cochrane Database Syst Rev. 2003(2):CD003494. Whitlock EP, Polen MR, Green CA, Orleans T, Klein J. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: A summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. Apr 2004;140(7):557-568. Bertholet N, Daeppen JB, Wietlisbach V, Fleming M, Burnand B. Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Arch Intern Med. May 9 2005;165(9):986-995. Solberg LI, Maciosek MV, Edwards NM. Primary care intervention to reduce alcohol misuse ranking its health impact and cost effectiveness. Am J Prev Med. Feb 2008;34(2):143-152. Jackson R, Johnson M, Campbell F, et al. Screening and brief interventions for prevention and early identification of alcohol use disorders in adults and young people. Sheffield: University of Sheffield, School of Health and Related Research (ScHARR) Public Health Collaborating Centre. 2010. Babor T, Robaina K, Nilsen P, Kaner E, Li Q. Rapid Review of Current Evidence for Health Promotion Actions for Hazardous and Harmful Alcohol Use, With Specific Reference to Low and Middle Income Countries. Geneva, Switzerland: World Health Organization, Mainstreaming Project, Division of Noncommunicable Diseases. 2011. Jackson R, Johnson M, Campbell F, et al. Screening and brief interventions for prevention and early identification of alcohol use disorders in adults and young people. Sheffield: University of Sheffield, School of Health and Related Research (ScHARR) Public Health Collaborating Centre. 2010. Jonas DE, Garbutt JC, Brown JM, et al. Screening, Behavioral Counseling, and Referral in Primary Care to Reduce Alcohol Misuse. 2012. McCance-Katz EF, Kosten TR. Psychopharmacological treatments. Clinical Textbook of Addictive Disorders. Vol 3. New York, NY: Guilford Press; 2005:588-614. Coviello DM, Cornish JW, Lynch KG, Alterman AI, O’Brien CP. A Randomized Trial of Oral Naltrexone for Treating Opioid‐Dependent Offenders. The American Journal on Addictions. 2010;19(5):422-432. Ries RK, Miller SC, Fiellin DA. Principles of Addiction Medicine. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009. Saitz R, Palfai TA, Cheng DM, et al. Screening and Brief Intervention for Drug Use in Primary Care: The ASPIRE Randomized Clinical Trial. JAMA. 2014;312(5):502-513. doi:10.1001/jama.2014.7862. Aalto M, Pekuri P, Seppa K. Obstacles to carrying out brief intervention for heavy drinkers in primary health care: a focus group study. Drug Alcohol Rev. Jun 2003;22(2):169-173. Roche AM, Freeman T. Brief interventions: good in theory but weak in practice. Drug Alcohol Rev. Mar 2004;23(1):11-18. Senior Vice President and Fellow Public Health Department NORC at the University of Chicago [email protected] ASPE Briefing: SBIRT in FQHCs 3-25-15 CE Certificate www.naadac.org/acaandaddictiontreatment Cost to Watch: Free CE Hours Available: 1 CE CE Certificate for NAADAC Members: Free CE Certificate for Non-members: $15 www.naadac.org/webinars WEBINAR SERIES Over 75 CEs of free educational webinars are available. Education credits are FREE for NAADAC members. Free CEs for Members Levels: Professional Associate Student To obtain a CE Certificate for the time you spent watching this webinar: 1. Watch this entire webinar. 2. Pass the online CE quiz, which is posted at www.naadac.org/acaandaddictiontreatment 3. If applicable, submit payment for CE certificate or join NAADAC. 4. A CE certificate will be emailed to you within 21 days of submitting the quiz. INDEPENDENT STUDY COURSES Earn CEs at home and at your own pace (includes study guide and online examination). MAGAZINE ARTICLES In each issue of Advances in Addiction & Recovery, NAADAC's magazine, one article is eligible for CEs. FACE-TO-FACE SEMINARS NAADAC offers face-to-face seminars of varying lengths in the U.S. and abroad. CONFERENCES NAADAC Annual Conference and Advocacy in Action Conference. CERTIFICATE PROGRAMS Demonstrate advanced education in diverse topics with the NAADAC Certificate Programs. www.naadac.org/ join 12 11/3/15 Contact Us! NAADAC 1001 N. Fairfax Street, Suite 201 Alexandria, VA 22314 phone: 703.741.7686 / 800.548.0497 fax: 703.741.7698 / 800.377.1136 [email protected] www.naadac.org NAADACorg Naadac NAADAC 13
© Copyright 2026 Paperzz